Bristol-Myers Squibb Co (BSP:BMYB34) Long-Term Capital Lease Obligation : R$7,783 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Long-Term Capital Lease Obligation?

Bristol-Myers Squibb Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was R$7,783 Mil.

Bristol-Myers Squibb Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (R$7,472 Mil) to Dec. 2023 (R$7,497 Mil) and increased from Dec. 2023 (R$7,497 Mil) to Mar. 2024 (R$7,783 Mil).

Bristol-Myers Squibb Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (R$4,942 Mil) to Dec. 2022 (R$6,614 Mil) and increased from Dec. 2022 (R$6,614 Mil) to Dec. 2023 (R$7,497 Mil).

Bristol-Myers Squibb Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Bristol-Myers Squibb Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Long-Term Capital Lease Obligation Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2,758.22

4,285.54

4,942.38

6,614.45

7,496.69

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															7,135.78	6,513.67	7,472.25	7,496.69	7,783.43

Bristol-Myers Squibb Co (BSP:BMYB34) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Bristol-Myers Squibb Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (BSP:BMYB34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (BSP:BMYB34) Headlines

No Headlines